Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them Grant US-11603367-B2 United States of America 14 Mar 2023
USE OF THE LAST C-TERMINAL RESIDUES M31/41 OF ZIKV M ECTODOMAIN FOR TRIGGERING APOPTOTIC… Application WO-2022101463-A1 World Intellectual Property Organisation (WIPO) 19 May 2022
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant US-11261171-B1 United States of America 01 Mar 2022
Combination of isoindolinone derivatives with SGI-110 Grant US-11236047-B2 United States of America 01 Feb 2022